Indoco Remedies has reported results for first quarter ended June 30, 2023 (Q1FY24).
The company has reported 32.57% fall in its net profit at Rs 25.94 crore for the quarter under review as compared to Rs 38.47 crore for the same quarter in the previous year. However, total income of the company increased by 3.49% at Rs 423.29 crore for Q1FY24 as compared Rs 409.03 crore for the corresponding quarter previous year.
On consolidated basis, the company has reported 37.31% fall in net profit at Rs 24.18 crore for the quarter ended June 30, 2023 as compared to Rs 38.57 crore for the same quarter in the previous year. However, total income of the company increased by 4.29% at Rs 426.91 crore for Q1FY24 as compared Rs 409.35 crore for the corresponding quarter previous year.
Company Name | CMP |
---|---|
Sun Pharma Inds. | 1504.25 |
Dr. Reddys Lab | 6263.70 |
Cipla | 1406.25 |
Zydus Lifesciences | 948.20 |
Lupin | 1615.85 |
View more.. |